Pharma Co. Wins Case For Vitamin D Pill At EPO
European officials have upheld EirGen Pharma's bid to patent a long-lasting formula designed to slowly release vitamin D to patients with chronic kidney disease, ruling the design was not obvious to...To view the full article, register now.
Already a subscriber? Click here to view full article